Drug Type Recombinant LBP |
Synonyms CBT 102 (CommBio), CBT102-A |
Target- |
Action modulators |
Mechanism Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Phenylketonurias | Phase 1 | China | - | 02 Sep 2023 |
Early Phase 1 | 10 | tbvdrtwuxp(dfojfrajyl) = qtkkinlcml acmijaxjir (nwdyreuays ) View more | Positive | 02 Jan 2024 |





